Primary record
2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine methanesulfonate
- 库存
- 3,546 克
- 纯度
- 98.9 %
- CAS
- 957054-30-7
化合物标识与属性
- CAS
- 957054-30-7
- PubChem CID
- 17755052
- SMILES
- CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6
- Canonical SMILES
- CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1
名称与同义词
- PICTILISIB
- Pictrelisib
- GDC-0941
- 957054-30-7
- GDC0941
- pictilisibum
- GDC 0941
- Pictrelisib [INN]
- ICY00EMP8P
- Pictilisib [USAN:INN]
- UNII-ICY00EMP8P
- GDC-0941 (Pictilisib)
- Pictilisib (GDC-0941)
- Kinome_3719
- PICTILISIB [MI]
- GDC0941(Pictilisib)
- PICTILISIB [INN]
- Pictilisib (USAN/INN)
- RefChem:929266
- PICTILISIB [USAN]
- GDC0941(Pictilisib)?
- cc-29
- D08QGT
- D0T1ZO
- C23H27N7O3S2
- PICTILISIB [WHO-DD]
- MFCD11616196
- CDC-0941
- CHEBI:65326
- MLS006010057
- 4-(2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine
- SCHEMBL190812
- DTXSID40241930
- CHEMBL521851
- GTPL5682
- orb1306809
- SCHEMBL14859338
- SCHEMBL29375636
- SCHEMBL29387739
- BDBM25028
- CTK8B8042
- 957054-30-7 (free base)
- DTXCID70164421
- EX-A167
- SYN1041
- 2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine
- LHNIIDJUOCFXAP-UHFFFAOYSA-N
- GLXC-90127
- HMS2043A16
- HMS3244H06
- HMS3244H10
- HMS3244H14
- HMS3265I05
- HMS3265I06
- HMS3265J05
- HMS3265J06
- HMS3654K13
- HMS3744A19
- AOB87310
- BCP01714
- EX-A1536
- GNE 0941
- KS-000006NA
- GDC-0941/GDC0941
- ABP000080
- ANW-59256
- NSC755385
- NSC800852
- RG7321
- RS0072
- s1065
- ZINC16052714
- AKOS015966503
- GDC-0941, GDC0941
- AN-5296
- BCP9000715
- CCG-264801
- CS-0081
- DB11663
- FI32904
- NSC-755385
- NSC-800852
- QC-4780
- RG-7321
- SB19941
- SDCCGSBI-0654334.P001
- NCGC00187482-01
- NCGC00187482-03
- NCGC00187482-10
- 4CA-0560
- AC-32623
- AJ-68088
- AK-40872
- AS-19377
- BC657908
- HY-50094
- SC-85717
- SMR004701219
- AB0033712
- TC-148001
- A8210
- FT-0696889
- NS00071518
- ST24039079
- SW202556-4
- X7409
- EC-000.2335
- J2.731.432E
- A10421
- A11168
- D10189
- Q-3925
- 054G307
- A845396
- Pictilisib (GDC0941, RG7321, GNE0941))
- 2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine
- 4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine
- Thieno[3,2-d]pyrimidine, 2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-
- BRD-K52911425-001-02-3
- BRD-K52911425-001-09-8
- Q27088388
- 2-(1H-indazol-4-yl)-6-((4-(methanesulfonyl)piperazin-1-yl)methyl)-4-(morpholin-4-yl)thieno(3,2-d)pyrimidine
- 4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno(3,2-d)pyrimidin-4-yl)morpholine
- 957054-50-1
- B0084-101126
- Thieno[3,2-d]pyrimidine, 2-(1H-indazol-4-yl)-6-[[4
- Thieno[3,2-d]pyrimidine,2- -6-[[4- -1-piperazinyl]methyl]-4- -
- 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine
- 2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine methanesulfonate
- 2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-(morpholin-4-yl)thieno[3,2-d]pyrimidine
- 2-(1h-Indazol-4-Yl)-6-{[4-(Methylsulfonyl)piperazin-1-Yl]methyl}-4-Morpholin-4-Yl-Thieno[3,2-D]pyrimidine
- 4-{6-[(4-methanesulfonylpiperazin-1-yl)methyl]-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-2-yl}-1H-indazole
- GD9
- Pictilisib, 98%, a potent inhibitor of PI3Kalpha/delta - 100MG 100mg
- THIENO(3,2-D)PYRIMIDINE, 2-(1H-INDAZOL-4-YL)-6-((4-(METHYLSULFONYL)-1-PIPERAZINYL)METHYL)-4-(4-MORPHOLINYL)-
- Thieno(3,2-d)pyrimidine, 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)-1-piperazinyl]methyl)-4-(4-morpholinyl)-
- 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-(morpholin-4-yl)thieno(3,2-d)pyrimidine
- 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidine
- 2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidi
- 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine
- 2-(1H-Indazol-4-yl)-6-{[4-(methanesulfonyl)piperazin-1-yl]methyl}-4-(morpholin-4-yl)thieno[3,2-d]pyrimidine
- 2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3,2-d]pyrimidine
- 4-(2-(1H-indazol-4-yl)-6-((4-methylsulfonylpiperazin-1-yl)methyl)thieno(3,2-d)pyrimidin-4-yl)morpholine
- 4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine
- 4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonyl-1-piperazinyl)methyl]-4-thieno[3,2-d]pyrimidinyl]morpholine
- 4-{6-[(4-methanesulfonylpiperazin-1-yl)methyl]-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-2-yl}-2H-indazole
- 6-[4-(Methylsulfonyl)piperazine-1-ylmethyl]-4-morpholino-2-(1H-indazole-4-yl)thieno[3,2-d]pyrimidine
- 936091-56-4
- 957054-33-0
- Methyl[4-[2-(1H-indazole-4-yl)-4-morpholinothieno[3,2-d]pyrimidine-6-ylmethyl]piperazino] sulfone
- Thieno[3,2-d]pyrimidine,2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-